References
- Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011;21(10):1049–1051
- Burch HB, Wartofsky L. Graves’ ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev 1993;14(6):747–793
- Nüssgens Z, Roggenkämper P, Schweikert HU. Development of endocrine orbitopathy in pregnancy. Klin Monbl Augenheilkd 1993;202(2):130–133
- Stafford IP, Dildy GA 3rd, Miller JM Jr. Severe Graves' ophthalmopathy in pregnancy. Obstet Gynecol 2005;105(5 Pt 2):1221–1223
- Gopinath B, Adams CL, Musselman R, et al. Antibodies against calsequestrin and type XIII collagen are good markers for chronic upper eyelid retraction. Ocul Immunol Inflamm 2007;15(2):81–88
- Shen S, Fong KS, Wong HB, et al. Normative measurements of the Chinese extraocular musculature by high-field magnetic resonance imaging. Invest Ophthalmol Vis Sci 2010;51(2):631–636
- Gaberscek S, Katel K. Thyroid physiology and autoimmunity in pregnancy and after delivery. Expert Rev Clin Immunolo 2011;7(5):697–707